# HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Cancer

> **NCT02449967** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Fuda Cancer Hospital, Guangzhou**

## Conditions studied

- Pancreatic Cancer

## Interventions

- **PROCEDURE:** interventional therapy

## Key facts

- **NCT ID:** NCT02449967
- **Lead sponsor:** Fuda Cancer Hospital, Guangzhou
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-05
- **Primary completion:** 2018-06
- **Final completion:** 2020-06
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2019-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02449967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02449967, "HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Cancer". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02449967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*